Form 8-K - Current report:
SEC Accession No. 0001654954-25-000805
Filing Date
2025-01-27
Accepted
2025-01-27 17:21:18
Documents
15
Period of Report
2025-01-22
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 FORM 8-K zivo_8k.htm   iXBRL 8-K 25537
  Complete submission text file 0001654954-25-000805.txt   161937

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zivo-20250122.xsd EX-101.SCH 6305
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE zivo-20250122_lab.xml EX-101.LAB 15780
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zivo-20250122_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zivo-20250122_pre.xml EX-101.PRE 11585
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zivo-20250122_def.xml EX-101.DEF 4194
17 EXTRACTED XBRL INSTANCE DOCUMENT zivo_8k_htm.xml XML 5380
Mailing Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304
Business Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304 (248) 452 9866
Zivo Bioscience, Inc. (Filer) CIK: 0001101026 (see all company filings)

EIN.: 870699977 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40449 | Film No.: 25560123
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)